South Africa Generics Medicine Market Outlook 2022
Access to therapeutic drugs form an integral part of any successful healthcare system. The high cost of drugs, however remains a barrier to accessibility and improved health to the majority of the South African population. The promotion of generic drug consumption was the answer to this issue, with its massive cost-saving mechanism in regard for the final consumers, insurance providers, and government. In 2001, the South African Government passed the law that allowed substitution of branded medicines with generic drugs, which in turn made South Africa a huge market space for the generic drug manufacturing pharmaceutical companies. Further, it is anticipated that the generic medicine market is forecasted to grow at a CAGR of around 12% during 2017-2022.
The report “South Africa Generics Medicine Market Outlook 2022” provides a current and future perspective of the market. It provides an overview of the Healthcare market of South Africa, focusing on its two major segments of Public Healthcare and Private Healthcare. It further gives a detailed analysis of the South African Pharmaceutical market, with an in-depth study of the Generic Drug market scenario prevalent in the country.
A detailed demographic analysis was carried out in the research to understand the significance of the generic market in South Africa, which revealed that HIV is the biggest threat to the country, as it results in the majority of casualties in the country. The other major epidemic is Tuberculosis and Hepatitis. Further, a meticulous disease wise segmentation has provided the holistic understanding of the healthcare-related demand parameters prevailing in the country.
The latter half of the report provides the status of the current rules and regulation that govern the Generic Drug market. It also focuses on the analysis of current trends, and the challenges of the market. Our research also talks about the competitive landscape of the key players, such as Teva, Aspen, Adcock Ingram, Cipla, and Pharma Dynamics. On the whole, the report provides information that will prove to be vital for investors interested in the domestic market.
The report “South Africa Generics Medicine Market Outlook 2022” provides a current and future perspective of the market. It provides an overview of the Healthcare market of South Africa, focusing on its two major segments of Public Healthcare and Private Healthcare. It further gives a detailed analysis of the South African Pharmaceutical market, with an in-depth study of the Generic Drug market scenario prevalent in the country.
A detailed demographic analysis was carried out in the research to understand the significance of the generic market in South Africa, which revealed that HIV is the biggest threat to the country, as it results in the majority of casualties in the country. The other major epidemic is Tuberculosis and Hepatitis. Further, a meticulous disease wise segmentation has provided the holistic understanding of the healthcare-related demand parameters prevailing in the country.
The latter half of the report provides the status of the current rules and regulation that govern the Generic Drug market. It also focuses on the analysis of current trends, and the challenges of the market. Our research also talks about the competitive landscape of the key players, such as Teva, Aspen, Adcock Ingram, Cipla, and Pharma Dynamics. On the whole, the report provides information that will prove to be vital for investors interested in the domestic market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
3.1 Demographic Profile
3.2 Prevalence of Major Diseases
3.2.1 HIV/AIDS
3.2.2 Tuberculosis
3.2.3 Influenza
3.2.4 Hepatitis
3.2.5 Diabetes
4. PHARMACEUTICAL MARKET OVERVIEW
4.1 Market by Top Players
4.2 Market by Top Medicines
5. GENERICS MEDICINE MARKET OUTLOOK TO 2022
5.1 Prescription
5.2 OTC
6. EMERGING MARKET TRENDS
6.1 Demand for HIV Generic Drug Persists
6.2 Lifestyle Diseases on a Rise
6.3 New Regulatory System in Motion
7. MARKET CHALLENGES
8. REGULATORY ENVIRONMENT
9. COMPETITIVE LANDSCAPE
9.1 Teva Pharmaceuticals
9.2 Aspen Generics
9.3 Adcock Ingram
9.4 Cipla Medpro South Africa
9.5 Pharma Dynamics
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
3.1 Demographic Profile
3.2 Prevalence of Major Diseases
3.2.1 HIV/AIDS
3.2.2 Tuberculosis
3.2.3 Influenza
3.2.4 Hepatitis
3.2.5 Diabetes
4. PHARMACEUTICAL MARKET OVERVIEW
4.1 Market by Top Players
4.2 Market by Top Medicines
5. GENERICS MEDICINE MARKET OUTLOOK TO 2022
5.1 Prescription
5.2 OTC
6. EMERGING MARKET TRENDS
6.1 Demand for HIV Generic Drug Persists
6.2 Lifestyle Diseases on a Rise
6.3 New Regulatory System in Motion
7. MARKET CHALLENGES
8. REGULATORY ENVIRONMENT
9. COMPETITIVE LANDSCAPE
9.1 Teva Pharmaceuticals
9.2 Aspen Generics
9.3 Adcock Ingram
9.4 Cipla Medpro South Africa
9.5 Pharma Dynamics
LIST OF FIGURES:
Figure 3-1: Total Healthcare Expenditure (Billion US$), 2010-2014
Figure 3-2: Public & Private Health Expenditure (%), 2010-2014
Figure 3-3: Comparison of Healthcare Spending by Countries (% of GDP), 2016
Figure 3-4: Major Causes of Death (%), 2015
Figure 3-5: HIV Patients (Million), 2013 & 2015
Figure 3-6: Active Tuberculosis Patients ('000), 2013 & 2015
Figure 3-7: Diabetes Patients (Million), 2013 & 2015
Figure 4-1: Pharmaceutical Market (Billion ZAR), 2015-2022
Figure 4-2: Pharmaceutical Market by Players (%), 2016
Figure 4-3: Pharmaceutical Market by Top Medicines (%), 2016
Figure 4-4: Pharmaceutical Market by Prescription/OTC (%), 2016
Figure 5-1: Generic Medicine in Pharmaceutical Market (%), 2016
Figure 5-2: Generic Medicine Market (Billion ZAR), 2015-2022
Figure 5-3: Generic Medicine Market by Segment (%), 2016
Figure 5-4: Generic Medicine in Prescription Market (%), 2016
Figure 5-5: Prescription Generic Medicine Market (Billion ZAR), 2015-2022
Figure 5-6: Generic Medicine in OTC Market (%), 2016
Figure 5-7: OTC Generic Medicine Market (Billion ZAR), 2015-2022
Figure 3-1: Total Healthcare Expenditure (Billion US$), 2010-2014
Figure 3-2: Public & Private Health Expenditure (%), 2010-2014
Figure 3-3: Comparison of Healthcare Spending by Countries (% of GDP), 2016
Figure 3-4: Major Causes of Death (%), 2015
Figure 3-5: HIV Patients (Million), 2013 & 2015
Figure 3-6: Active Tuberculosis Patients ('000), 2013 & 2015
Figure 3-7: Diabetes Patients (Million), 2013 & 2015
Figure 4-1: Pharmaceutical Market (Billion ZAR), 2015-2022
Figure 4-2: Pharmaceutical Market by Players (%), 2016
Figure 4-3: Pharmaceutical Market by Top Medicines (%), 2016
Figure 4-4: Pharmaceutical Market by Prescription/OTC (%), 2016
Figure 5-1: Generic Medicine in Pharmaceutical Market (%), 2016
Figure 5-2: Generic Medicine Market (Billion ZAR), 2015-2022
Figure 5-3: Generic Medicine Market by Segment (%), 2016
Figure 5-4: Generic Medicine in Prescription Market (%), 2016
Figure 5-5: Prescription Generic Medicine Market (Billion ZAR), 2015-2022
Figure 5-6: Generic Medicine in OTC Market (%), 2016
Figure 5-7: OTC Generic Medicine Market (Billion ZAR), 2015-2022
LIST OF TABLES:
Table 3-1: Demographic Characteristics (2015)
Table 9-1: Teva Pharmaceuticals - Key Financials (Million US$), 2013-2015
Table 9-2: Aspen Holdings - Key Financials (Million ZAR), 2013-2015
Table 9-3: Adcock Ingram - Key Financials (Million ZAR), 2013-2015
Table 9-4: Cipla Medpro - Key Financials (Million ZAR), 2014-2015
Table 9-5: Pharma Dynamics - Key Financials (Million ZAR), 2014-2015
Table 3-1: Demographic Characteristics (2015)
Table 9-1: Teva Pharmaceuticals - Key Financials (Million US$), 2013-2015
Table 9-2: Aspen Holdings - Key Financials (Million ZAR), 2013-2015
Table 9-3: Adcock Ingram - Key Financials (Million ZAR), 2013-2015
Table 9-4: Cipla Medpro - Key Financials (Million ZAR), 2014-2015
Table 9-5: Pharma Dynamics - Key Financials (Million ZAR), 2014-2015
